Comparison of the safety and persistence of immunogenicity of bivalent HPV16/18 vaccine in healthy 9–14-year-old and 18–26-year-old Chinese females: A randomized, double-blind, non-inferiority clinical trial

Autor: Li, Juan, Shi, Li-Wei, Li, Ke, Huang, Li-Rong, Li, Jian-Biao, Dong, Yu-Lian, Li, Wei, Ji, Min, Yang, Qing, Zhou, Ling-Yun, Yuan, Lin, Yan, Xue-Mei, Chen, Jing-Jing, Jiang, Zhi-Wei, Qi, Yang-Yang, Li, Rong-Cheng, Li, Yan-Ping, Xia, Jie-Lai, Yu, Bang-Wei, Mo, Zhao-Jun, Li, Chang-Gui
Zdroj: In Vaccine 22 November 2023 41(48):7212-7219
Databáze: ScienceDirect
Externí odkaz: